Fantappiè and collaborators demonstrated that vitamin E prevents HCC development in mice by downregulating nitric oxide synthase (iNOS) and NADPH oxidase [235], and it also protects against ROS-induced DNA damage in HCC cells [236]. Here, FMO5 is linked to hepatocellular carcinoma.